Delivery Order SPE2DB22D3004-SPE2DB24FPC90
Award Date 1/29/24
Potential Completion Date 1/30/24
Potential Value $1.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,563,956,809 units of Abiraterone Acetate 250 mg tablets. The $1,742.07 award has a performance period through March 14, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563636913 - Abiraterone Acetate 250 MG Tab 120S. The contract is valued at $1,423.04 and has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not associated with any set-aside designation. The contract is part...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,082.28, is for the delivery of 4,563,885,927 units of Abiraterone Acetate 250 mg tablets. The contract has a completion date of March 8, 2024 and is a Firm Fixed Price Delivery Order. The award was made on March 7, 2024 and there was no set-aside designation used. AmerisourceBergen Drug Corp holds a...
- The Defense Logistics Agency awarded a delivery order valued at $25,329.84 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count) under a firm fixed-price contract. The delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This contract was competitively awarded without set-aside designation, reflecting open competition among...
- This is a $1,726.35 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4,567,100,912 units of abiraterone acetate 500 mg tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Abiraterone Acetate 250 mg tablets in a quantity of 120 units, with a ceiling value of $6,437.79. This is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This federal contract award, with ID SPE2DB20D2200|SPE2DB25FW80J, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.03 firm fixed-price delivery order is for the supply of 4,568,062,183 units of the pharmaceutical product Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $20,776.45 on June 11, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of June 12, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order falls...